Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

NCT02564900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: DS-8201a (DP1)
DRUG: DS-8201a (DP2)
DRUG: DS-8201a (DP)

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]
[object Object]